Detects the acquired JAK2 V617F mutation in white blood cells using real-time PCR.
Used alongside the CBC, clinical findings and other investigations to support the diagnosis of BCR::ABL1-negative myeloproliferative neoplasms, particularly polycythaemia vera, essential thrombocythaemia and primary myelofibrosis.